The Biology of CancerJanice Ann Gabriel John Wiley & Sons, 27 Eyl 2007 - 216 sayfa Advances in research and the treatment of cancer mean that more patients and their carers are asking healthcare professionals about the latest treatments and how they may be of benefit. It is essential that staff working with cancer patients understand fully how these new treatments work in order to disseminate timely and appropriate information to patients. The application of biology to the delivery of cancer care is playing an ever-increasing role in the management of these diseases. The Biology of Cancer: Second Edition provides details of the most recent developments in cancer care and is divided into three sections:
This fully updated edition also looks at evidence-based research that can be translated directly to patient care and gives details recent developments. Written by experienced, practicing healthcare professionals, The Biology of Cancer: Second Edition can easily be applied to patient care. It is an informative text for students, newly qualified nurses and practising oncology/palliative care nurses. |
İçindekiler
1 | |
3 | |
11 | |
3 Cancer What Does a Diagnosis Mean for an Individual and What Are the Implications for Society? | 23 |
Part II The Science of Cancer | 31 |
4 The Cell | 33 |
5 Cytotoxic Chemotherapy | 45 |
6 What Are DNA and RNA? | 55 |
9 Tumour Markers | 99 |
10 Monoclonal Antibodies | 111 |
Part III From Research to Treatment | 125 |
11 What is Translational Oncology Research? | 127 |
12 The Application of Research Methodology to Cancer Research | 135 |
13 Research Ethics Relating to Cancer | 153 |
Glossary | 167 |
References | 171 |
Diğer baskılar - Tümünü görüntüle
Sık kullanılan terimler ve kelime öbekleri
2007 John Wiley activation amino acid angiogenesis anticancer apoptosis assay Bevacizumab binding Biology of Cancer blood body breast cancer cancer cells cancer patients Cancer Research cancer services CD4+ T-cells CD8+ cell cycle cetuximab chemotherapy chromosome clinical trials co-stimulatory codon colorectal cancer cytokines diagnosis disease drugs effects ensure enzymes example exposure Frogge and Goodman Gabriel genetic genome growth factor health-care helper T-cells Herceptin human cancers human tumour identified immune responses immune system increase individual infection involved leukaemia linked lung lymphocytes lymphoma mAbs macrophages metastatic methylation molecular molecules monoclonal antibodies mRNA mutations NHS Cancer Plan NK cells normal cells nursing Oncology outcomes participants pathogens phase potential produce proliferation protein qualitative research receptor replication rituximab sample screening signal specific T-lymphocytes therapeutic therapy tissue translational oncology research trastuzumab treatment tumour antigens tumour cells tumour markers types United Kingdom vaccines Yarbro